BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
4.140
-0.010 (-0.24%)
At close: Dec 26, 2025, 4:00 PM EST
4.040
-0.100 (-2.42%)
After-hours: Dec 26, 2025, 7:59 PM EST
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $9.79 million as of December 26, 2025. Its market cap has increased by 85.95% in one year.
Market Cap
9.79M
Enterprise Value
6.91M
1-Year Change
85.95%
Ranking
Category
Stock Price
$4.14
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $9.79M, a decrease of -76.77%. That is a compound annual growth rate of -24.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 9.79M | 94.73% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 198.41B |
| BHP Group | 155.43B |
| Rio Tinto Group | 137.99B |
| Southern Copper | 121.33B |
| Newmont | 114.10B |
| Agnico Eagle Mines | 91.04B |
| CRH plc | 85.49B |
| The Sherwin-Williams Company | 80.19B |